Showing results (761-770 of 805) with videos related to

Sort By:
Pageof 81
Medical Oncology (Northwood, London, England)|February 15, 2013
Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancerMin Dong, Xiang-bo Wan, Zhong Yu Yuan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2014
Hepatitis B virus DNA negativity acts as a favorable prognostic factor in hepatocellular carcinoma patientsXing Li, Xiang Zhong, Zhan-Hong Chen, et al.
Journal of Multidisciplinary Healthcare|October 13, 2022
The Effectiveness of Multidisciplinary Team Huddles in Healthcare Hospital-Based SettingShih Ping Lin, Ching-Wein Chang, Chun-Yi Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 5, 2025
ZAR1/2-Regulated Epigenetic Modifications are Essential for Age-Associated Oocyte Quality Maintenance and Zygotic ActivationYan Rong, Yu-Ke Wu, Yingyan Chen, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 9, 2016
Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial ChemoembolizationXing Li, Xiang Zhong, Zhan-Hong Chen, et al.
Oncology Reports|July 15, 2014
Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancerMin Dong, Xin-Juan Fan, Zhan-Hong Chen, et al.
Bing Du Xue Bao = Chinese Journal of Virology|July 31, 2013
[Rash and fever illness caused by herpes simplex virus type 1 needs to be distinguished from hand, foot and mouth disease]Shuang-Li Zhu, Jian-Feng Liu, Qiang Sun, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 7, 2014
Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinomaXing Li, Zhan-Hong Chen, Xiao-Kun Ma, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 13, 2015
Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinomaYing-Fen Hong, Zhan-Hong Chen, Xiao-Kun Ma, et al.
Oncology Letters|July 12, 2017
Validation and ranking of seven staging systems of hepatocellular carcinomaZhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, et al.
Pageof 81